# TKO Group Holdings, Inc.: financial statements, quarterly

TKO · NYSE · CIK 1973266 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/tko.md) · [Financials](/companies/tko/financials.md) · [Filings](/companies/tko/filings.md) · [Insiders](/companies/tko/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/tko/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [449](/filings/0000950170-24-122364.md) | [2,164 d](/filings/0001193125-26-071651.md) | [1,222](/filings/0001193125-26-071651.md) | [1,193](/filings/0001193125-26-071651.md) | [1,541](/filings/0001193125-26-071651.md) | [928](/filings/0001193125-26-071651.md) | [1,269](/filings/0001193125-26-208992.md) | [1,308](/filings/0001193125-26-330592.md) | [1,120](/filings/0001193125-26-071651.md) | [1,038](/filings/0001193125-26-071651.md) | [1,597](/filings/0001193125-26-208992.md) | [1,547](/filings/0001193125-26-330592.md) |
| Selling, general and administrative | $m | [193](/filings/0000950170-24-122364.md) | [714 d](/filings/0001193125-26-071651.md) | [668](/filings/0000950170-25-067220.md) | [368](/filings/0000950170-25-104095.md) | [380](/filings/0001193125-25-267014.md) | [355 d](/filings/0001193125-26-071651.md) | [363](/filings/0001193125-26-208992.md) | [364](/filings/0001193125-26-330592.md) | [379](/filings/0001193125-25-267014.md) | [405 d](/filings/0001193125-26-071651.md) | [380](/filings/0001193125-26-208992.md) | [463](/filings/0001193125-26-330592.md) |
| Operating income | $m | [93.8](/filings/0000950170-24-122364.md) | [(8.0) d](/filings/0001193125-26-071651.md) | [(174)](/filings/0001193125-26-071651.md) | [115](/filings/0001193125-26-071651.md) | [34.6](/filings/0001193125-26-071651.md) | [55.0](/filings/0001193125-26-071651.md) | [237](/filings/0001193125-26-208992.md) | [368](/filings/0001193125-26-330592.md) | [172](/filings/0001193125-26-071651.md) | [57.4](/filings/0001193125-26-071651.md) | [338](/filings/0001193125-26-208992.md) | [430](/filings/0001193125-26-330592.md) |
| Interest expense | $m | [60.6](/filings/0000950170-24-122364.md) | [57.2 d](/filings/0001193125-26-071651.md) | [61.2](/filings/0000950170-25-067220.md) | [63.0](/filings/0000950170-25-104095.md) | [59.4](/filings/0001193125-25-267014.md) | [52.2 d](/filings/0001193125-26-071651.md) | [44.8](/filings/0001193125-26-208992.md) | [48.2](/filings/0001193125-26-330592.md) | [50.8](/filings/0001193125-25-267014.md) | [58.9 d](/filings/0001193125-26-071651.md) | [60.6](/filings/0001193125-26-208992.md) | [70.6](/filings/0001193125-26-330592.md) |
| Income tax | $m | [11.2](/filings/0000950170-24-122364.md) | [15.5 d](/filings/0001193125-26-071651.md) | [(5.7)](/filings/0000950170-25-067220.md) | [6.6](/filings/0000950170-25-104095.md) | [2.9](/filings/0001193125-25-267014.md) | [33.5 d](/filings/0001193125-26-071651.md) | [21.2](/filings/0001193125-26-208992.md) | [46.5](/filings/0001193125-26-330592.md) | [12.8](/filings/0001193125-25-267014.md) | [(6.7) d](/filings/0001193125-26-071651.md) | [34.0](/filings/0001193125-26-208992.md) | [53.2](/filings/0001193125-26-330592.md) |
| Net income | $m | [(21.9)](/filings/0000950170-24-122364.md) | [(13.3) d](/filings/0001193125-26-071651.md) | [(104)](/filings/0001193125-26-071651.md) | [59.1](/filings/0001193125-26-071651.md) | [23.1](/filings/0001193125-26-071651.md) | [31.0](/filings/0001193125-26-071651.md) | [58.4](/filings/0001193125-26-208992.md) | [98.4](/filings/0001193125-26-330592.md) | [41.0](/filings/0001193125-26-071651.md) | [(2.4)](/filings/0001193125-26-071651.md) | [89.4](/filings/0001193125-26-208992.md) | [102](/filings/0001193125-26-330592.md) |
| Diluted EPS | $ per share | [(0.26)](/filings/0000950170-24-122364.md) | not reported | [(1.26)](/filings/0001193125-26-071651.md) | [0.72](/filings/0001193125-26-071651.md) | [0.28](/filings/0001193125-26-071651.md) | [0.28](/filings/0001193125-26-071651.md) | [0.69](/filings/0001193125-26-208992.md) | [1.17](/filings/0001193125-26-330592.md) | [0.47](/filings/0001193125-26-071651.md) | [(0.08)](/filings/0001193125-26-071651.md) | [1.12](/filings/0001193125-26-208992.md) | [1.34](/filings/0001193125-26-330592.md) |
| Basic EPS | $ per share | [(0.26)](/filings/0000950170-24-122364.md) | not reported | [(1.26)](/filings/0001193125-26-071651.md) | [0.73](/filings/0001193125-26-071651.md) | [0.29](/filings/0001193125-26-071651.md) | [0.38](/filings/0001193125-26-071651.md) | [0.72](/filings/0001193125-26-208992.md) | [1.20](/filings/0001193125-26-330592.md) | [0.50](/filings/0001193125-26-071651.md) | [(0.03)](/filings/0001193125-26-071651.md) | [1.16](/filings/0001193125-26-208992.md) | [1.36](/filings/0001193125-26-330592.md) |

- Revenue: us-gaap:Revenues
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.2](/filings/0001973266-23-000009.md) | [0.2](/filings/0000950170-25-027778.md) | [0.2](/filings/0001973266-24-000013.md) | [0.3](/filings/0001973266-24-000021.md) | [0.5](/filings/0000950170-24-122364.md) | [0.6](/filings/0001193125-26-071651.md) | [0.5](/filings/0000950170-25-067220.md) | [0.5](/filings/0000950170-25-104095.md) | [0.9](/filings/0001193125-25-267014.md) | [0.8](/filings/0001193125-26-330592.md) | [0.8](/filings/0001193125-26-208992.md) | [0.6](/filings/0001193125-26-330592.md) |
| Current assets | $bn | [0.5](/filings/0001973266-23-000009.md) | [0.5](/filings/0000950170-25-027778.md) | [0.6](/filings/0001973266-24-000013.md) | [0.7](/filings/0001973266-24-000021.md) | [0.9](/filings/0000950170-24-122364.md) | [1.5](/filings/0001193125-26-071651.md) | [1.5](/filings/0000950170-25-067220.md) | [1.9](/filings/0000950170-25-104095.md) | [2.2](/filings/0001193125-25-267014.md) | [2.3](/filings/0001193125-26-330592.md) | [2.9](/filings/0001193125-26-208992.md) | [3.2](/filings/0001193125-26-330592.md) |
| Total assets | $bn | [12.7](/filings/0001973266-23-000009.md) | [12.7](/filings/0000950170-25-027778.md) | [12.7](/filings/0001973266-24-000013.md) | [12.7](/filings/0001973266-24-000021.md) | [12.8](/filings/0000950170-24-122364.md) | [15.1](/filings/0001193125-26-071651.md) | [15.0](/filings/0000950170-25-067220.md) | [15.3](/filings/0000950170-25-104095.md) | [15.5](/filings/0001193125-25-267014.md) | [15.5](/filings/0001193125-26-330592.md) | [16.0](/filings/0001193125-26-208992.md) | [16.3](/filings/0001193125-26-330592.md) |
| Current liabilities | $bn | [0.4](/filings/0001973266-23-000009.md) | [0.5](/filings/0000950170-25-027778.md) | [0.6](/filings/0001973266-24-000013.md) | [0.8](/filings/0001973266-24-000021.md) | [0.8](/filings/0000950170-24-122364.md) | [1.4](/filings/0001193125-26-071651.md) | [1.2](/filings/0000950170-25-067220.md) | [1.5](/filings/0000950170-25-104095.md) | [1.5](/filings/0001193125-25-267014.md) | [1.8](/filings/0001193125-26-330592.md) | [2.2](/filings/0001193125-26-208992.md) | [2.5](/filings/0001193125-26-330592.md) |
| Total liabilities | $bn | [3.8](/filings/0001973266-23-000009.md) | [3.8](/filings/0000950170-25-027778.md) | [4.1](/filings/0001973266-24-000013.md) | [4.1](/filings/0001973266-24-000021.md) | [4.1](/filings/0000950170-24-122364.md) | [5.0](/filings/0001193125-26-071651.md) | [4.8](/filings/0000950170-25-067220.md) | [5.0](/filings/0000950170-25-104095.md) | [6.1](/filings/0001193125-25-267014.md) | [6.2](/filings/0001193125-26-330592.md) | [7.5](/filings/0001193125-26-208992.md) | [7.9](/filings/0001193125-26-330592.md) |
| Long-term debt | $bn | [2.7](/filings/0001973266-23-000009.md) | [2.7](/filings/0000950170-25-027778.md) | [2.7](/filings/0001973266-24-000013.md) | [2.7](/filings/0001973266-24-000021.md) | [2.7](/filings/0000950170-24-122364.md) | [2.7](/filings/0001193125-26-071651.md) | [2.7](/filings/0000950170-25-067220.md) | [2.7](/filings/0000950170-25-104095.md) | [3.7](/filings/0001193125-25-267014.md) | [3.7](/filings/0001193125-26-330592.md) | [4.6](/filings/0001193125-26-208992.md) | [4.6](/filings/0001193125-26-330592.md) |
| Current portion of debt | $bn | [0.0](/filings/0001973266-23-000009.md) | [0.0](/filings/0000950170-25-027778.md) | [0.0](/filings/0001973266-24-000013.md) | [0.0](/filings/0001973266-24-000021.md) | [0.0](/filings/0000950170-24-122364.md) | [0.0](/filings/0001193125-26-071651.md) | [0.0](/filings/0000950170-25-067220.md) | [0.0](/filings/0000950170-25-104095.md) | [0.0](/filings/0001193125-25-267014.md) | [0.0](/filings/0001193125-26-330592.md) | [0.0](/filings/0001193125-26-208992.md) | [0.0](/filings/0001193125-26-330592.md) |
| Shareholders' equity | $bn | [4.2](/filings/0001973266-23-000009.md) | [4.1](/filings/0000950170-25-027778.md) | [4.0](/filings/0001973266-24-000013.md) | [4.0](/filings/0001973266-24-000021.md) | [4.0](/filings/0000950170-24-122364.md) | [4.1](/filings/0001193125-26-071651.md) | [4.2](/filings/0000950170-25-067220.md) | [4.3](/filings/0000950170-25-104095.md) | [3.8](/filings/0001193125-25-267014.md) | [3.7](/filings/0001193125-26-330592.md) | [3.4](/filings/0001193125-26-208992.md) | [3.4](/filings/0001193125-26-330592.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [67.0 d](/filings/0000950170-24-122364.md) | [18.5 d](/filings/0001193125-26-071651.md) | [44.9](/filings/0000950170-25-067220.md) | [307 d](/filings/0000950170-25-104095.md) | [178 d](/filings/0001193125-25-267014.md) | [56.1 d](/filings/0001193125-26-071651.md) | [163](/filings/0001193125-26-208992.md) | [396 d](/filings/0001193125-26-330592.md) | [417 d](/filings/0001193125-25-267014.md) | [310 d](/filings/0001193125-26-071651.md) | [695](/filings/0001193125-26-208992.md) | [374 d](/filings/0001193125-26-330592.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | [31.1](/filings/0001193125-26-208992.md) | [31.1 d](/filings/0001193125-26-330592.md) | [62.4 d](/filings/0001193125-25-267014.md) | [60.6 d](/filings/0001193125-26-071651.md) | [58.5](/filings/0001193125-26-208992.md) | [58.9 d](/filings/0001193125-26-330592.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | [0.0 d](/filings/0001193125-25-267014.md) | [0.0 d](/filings/0001193125-26-071651.md) | not reported | not reported | not reported | [40.7 d](/filings/0001193125-26-071651.md) | [838](/filings/0001193125-26-208992.md) | [129 d](/filings/0001193125-26-330592.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [83.2](/filings/0000950170-24-122364.md) | [82.4](/filings/0000950170-25-067220.md) | [81.9](/filings/0000950170-25-104095.md) | [172](/filings/0001193125-25-267014.md) | [182](/filings/0001193125-26-208992.md) | [199](/filings/0001193125-26-330592.md) | [199](/filings/0001193125-25-267014.md) | [195](/filings/0001193125-26-208992.md) | [75.9](/filings/0001193125-26-330592.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.